Sana Biotechnology, Inc. (SANA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:00AM EDT. Market open.
| Previous Close | 7.81 |
| Open | 7.80 |
| Bid | 7.63 x 300 |
| Ask | 7.71 x 200 |
| Day's Range | 7.61 - 7.91 |
| 52 Week Range | 2.74 - 12.00 |
| Volume | |
| Avg. Volume | 1,650,622 |
| Market Cap | 1.699B |
| Beta (5Y Monthly) | 1.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.52 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.40 |
GlobeNewswireSana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s pluripotent stem cell-derived glial progenitor cell product candidate SEATTLE, May 21, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today highlighted that Nature Biotechnology has published a paper titled “You
Simply Wall St.Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Sana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial Results
Aligns with Analyst Projections Amidst Strategic Clinical Advancements
© 2024 Yahoo. All rights reserved.